 |
MorphoSys AG
MOR
|
1.02 |
- |
2.43 % |
$ 254 M |
Germany |
 |
AbCellera Biologics
ABCL
|
3.48 |
$ 3.56 |
- |
$ 1.06 B |
Canada |
 |
Acorda Therapeutics
ACOR
|
1.61 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Acasti Pharma
ACST
|
13.4 |
- |
4.01 % |
$ 150 M |
Canada |
 |
Advaxis
ADXS
|
5.93 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
AC Immune SA
ACIU
|
1.95 |
$ 3.13 |
- |
$ 229 M |
Schweiz |
 |
I-Mab
IMAB
|
8.96 |
- |
- |
$ 866 M |
China |
 |
Aeglea BioTherapeutics
AGLE
|
12.4 |
- |
- |
$ 1.01 B |
USA |
 |
AgeX Therapeutics
AGE
|
1.81 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 |
- |
- |
$ 40.3 B |
USA |
 |
Biophytis SA
BPTS
|
1.34 |
- |
-13.47 % |
$ 169 M |
France |
 |
Albireo Pharma
ALBO
|
2.39 |
- |
-0.23 % |
$ 916 M |
USA |
 |
Aileron Therapeutics
ALRN
|
7.98 |
- |
10.36 % |
$ 9.8 M |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
ADC Therapeutics SA
ADCT
|
1.2 |
$ 4.22 |
- |
$ 105 M |
Schweiz |
 |
Aptorum Group Limited
APM
|
3.71 |
$ 0.79 |
0.01 % |
$ 4.31 M |
China |
 |
Midatech Pharma plc
MTP
|
2.29 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
argenx SE
ARGX
|
8.81 |
$ 703.3 |
- |
$ 25 B |
Niderland |
 |
Adverum Biotechnologies
ADVM
|
1.65 |
- |
- |
$ 86.2 M |
USA |
 |
Ascendis Pharma A/S
ASND
|
0.889 |
$ 231.03 |
2.23 % |
$ 5 B |
Danmark |
 |
Alterity Therapeutics Limited
ATHE
|
7.02 |
$ 3.61 |
- |
$ 8.69 B |
Australia |
 |
Atea Pharmaceuticals
AVIR
|
7.92 |
$ 6.05 |
- |
$ 493 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.79 |
- |
- |
$ 26.5 M |
USA |
 |
Applied Molecular Transport
AMTI
|
2.31 |
- |
- |
$ 10.1 M |
USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
4.74 |
$ 6.63 |
- |
$ 182 M |
Israel |
 |
BioCardia
BCDA
|
0.651 |
$ 1.27 |
- |
$ 26.9 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
1.04 |
- |
- |
- |
Russia |
 |
Akero Therapeutics
AKRO
|
10.9 |
- |
- |
$ 3.67 B |
USA |
 |
Athersys
ATHX
|
2.38 |
- |
3.77 % |
$ 22.4 M |
USA |
 |
Akouos
AKUS
|
6.18 |
- |
0.23 % |
$ 488 M |
USA |
 |
Acer Therapeutics
ACER
|
0.41 |
- |
2.71 % |
$ 14 M |
USA |
 |
ARCA biopharma
ABIO
|
28.7 |
- |
1052.0 % |
$ 415 M |
USA |
 |
Allena Pharmaceuticals
ALNA
|
2.19 |
- |
3.16 % |
$ 1.9 M |
USA |
 |
Aeterna Zentaris
AEZS
|
1.6 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AlloVir
ALVR
|
22.6 |
- |
4.14 % |
$ 49.1 M |
USA |
 |
Catalyst Biosciences
CBIO
|
6.97 |
$ 11.58 |
- |
$ 1.03 B |
USA |
 |
Cerus Corporation
CERS
|
1.41 |
$ 1.8 |
6.51 % |
$ 343 M |
USA |
 |
Anika Therapeutics
ANIK
|
14.4 |
$ 14.36 |
- |
$ 210 M |
USA |
 |
Aptinyx
APTX
|
2.35 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
BioNTech SE
BNTX
|
7.95 |
$ 90.54 |
- |
$ 27.2 B |
Germany |
 |
Aptose Biosciences
APTO
|
0.69 |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
Burford Capital Limited
BUR
|
2.14 |
$ 8.05 |
- |
$ 1.34 B |
Britain |
 |
AVEO Pharmaceuticals
AVEO
|
1.77 |
- |
- |
$ 521 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
6.43 |
- |
- |
$ 7.46 M |
Israel |
 |
CNS Pharmaceuticals
CNSP
|
3.45 |
$ 2.45 |
0.41 % |
$ 936 K |
USA |
 |
Aytu BioScience
AYTU
|
1.47 |
$ 2.64 |
- |
$ 16.6 M |
USA |
 |
Cardiff Oncology
CRDF
|
3.75 |
$ 1.9 |
- |
$ 127 M |
USA |
 |
CorMedix
CRMD
|
1.96 |
$ 6.54 |
- |
$ 471 K |
USA |
 |
Avenue Therapeutics
ATXI
|
3.27 |
- |
-52.27 % |
$ 4.45 M |
USA |
 |
Autolus Therapeutics plc
AUTL
|
2.2 |
$ 1.51 |
- |
$ 385 M |
Britain |